Drug Type Small molecule drug |
Synonyms HND 01, HND01 |
Target |
Action inhibitors |
Mechanism BTK C481S inhibitors(Bruton Tyrosine Kinase C481S inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Preclinical | China | 27 Dec 2023 | |
| Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | China | 27 Dec 2023 | |
| Rheumatoid Arthritis | Preclinical | China | 27 Dec 2023 | |
| Lymphoma | Preclinical | China | 17 Apr 2023 | |
| B-Cell Leukemia | Preclinical | China | 04 Apr 2023 |





